Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch

Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States - Mexico border

Joan P Baumbach email, Lily N Foster email, Mark Mueller email, Michelle Firestone Cruz email, Sonia Arbona email, Sharon Melville email, Rebeca Ramos email and Steffanie A Strathdee email

Harm Reduction Journal 2008, 5:33doi:10.1186/1477-7517-5-33

Published: 16 November 2008

Abstract (provisional)

Background

The region situated where the borders of Mexico, Texas and New Mexico meet is known as 'Paso del Norte'. The Paso del Norte Collaborative was formed to study the seroprevalence of select pathogens and associated risk behaviors among injection drug users (IDUs) in the region.

Methods

Respondent-driven sampling (RDS) was used: 459 IDU participants included 204 from Mexico; 155 from Texas; and 100 from New Mexico. Each of the three sites used a standardized questionnaire that was verbally administered and testing was performed for select bloodborne infections.

Results

Participants were mostly male (87.4%) and Hispanic/Latino (84.7%) whose median age was 38. In Mexico, Texas and New Mexico, respectively: hepatitis B virus (HBV) was seen in 88.3%, 48.6% and 59.6% of participants; hepatitis C virus (HCV) in 98.7%, 76.4% and 80.0%; human immunodeficiency virus (HIV) in 2.1%, 10.0% and 1.0%; and syphilis in 4.0%, 9.9% and 3.0%. Heroin was the drug injected most often. More IDUs in New Mexico were aware of and used needle exchange programs compared with Texas and Mexico.

Conclusions

There was mixed success using RDS: it was more successfully applied after establishing good working relationships with IDU populations. Study findings included similarities and distinctions between the three sites that will be used to inform prevention interventions.

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.